免疫生物研究所（4570）の空売り残高
免疫生物研究所（4570）は、機関投資家による空売り残高（繰越合計）が現在ありません（最後に残高があったのは 2026/06/04）。個人等による空売り残高の報告がある場合は、下の表・グラフに掲載しています。
空売り残高（合計）の推移
- JPM Securities Japan Co
- GOLDMAN SACHS
- モルガン・スタンレーMUFG証券
- Barclays Capital Securities
- Nomura
- JANE STREET SINGAPORE
- Citigroup Global Markets
空売り者ごとの積み上げ（直近半年）。下の表は合計を最大12ヶ月分の数値で掲載。
繰越を反映した営業日ごとの空売り残高 合計（新しい順・直近90日を表示）。
| 計算日 | 残高数量（合計） | 残高割合 |
|---|---|---|
| 2026/03/17 | 441,264 | 4.73% (0.00%) |
| 2026/03/16 | 441,264 | 4.73% (+0.04%) |
| 2026/03/13 | 437,564 | 4.69% (+0.11%) |
| 2026/03/12 | 427,664 | 4.58% (+0.14%) |
| 2026/03/11 | 414,864 | 4.44% (+2.43%) |
| 2026/03/10 | 187,689 | 2.01% (-2.05%) |
| 2026/03/09 | 379,064 | 4.06% (+0.13%) |
| 2026/03/06 | 366,664 | 3.93% (-0.03%) |
| 2026/03/05 | 370,664 | 3.96% (-0.25%) |
| 2026/03/04 | 393,864 | 4.21% (-0.65%) |
| 2026/03/03 | 453,964 | 4.86% (0.00%) |
| 2026/03/02 | 453,964 | 4.86% (+0.01%) |
| 2026/02/27 | 453,264 | 4.85% (-0.41%) |
| 2026/02/26 | 492,264 | 5.26% (0.00%) |
| 2026/02/25 | 492,264 | 5.26% (-0.22%) |
| 2026/02/24 | 513,164 | 5.48% (-0.63%) |
| 2026/02/20 | 570,864 | 6.11% (+0.50%) |
| 2026/02/19 | 525,964 | 5.61% (+0.12%) |
| 2026/02/18 | 514,384 | 5.49% (+1.03%) |
| 2026/02/17 | 417,844 | 4.46% (-1.23%) |
| 2026/02/16 | 531,484 | 5.69% (-0.33%) |
| 2026/02/13 | 562,964 | 6.02% (+1.12%) |
| 2026/02/12 | 458,664 | 4.90% (-0.11%) |
| 2026/02/10 | 467,264 | 5.01% (-0.56%) |
| 2026/02/09 | 520,664 | 5.57% (-0.32%) |
| 2026/02/06 | 550,864 | 5.89% (-0.21%) |
| 2026/02/05 | 569,664 | 6.10% (-0.94%) |
| 2026/02/04 | 657,464 | 7.04% (+0.07%) |
| 2026/02/03 | 650,364 | 6.97% (-0.98%) |
| 2026/02/02 | 742,564 | 7.95% (+0.43%) |
機関別の空売り残高（過去12ヶ月の報告）
直近12ヶ月の機関別 空売り残高の報告（計算日の新しい順、全246件中 直近90件を表示）。
| 空売り者 | 計算日 | 残高数量 | 残高割合 |
|---|---|---|---|
| モルガン・スタンレーMUFG証券 | 3/2 | 138,975 | 1.49% (-0.08%) |
| GOLDMAN SACHS | 3/2 | 130,589 | 1.40% (+0.03%) |
| Barclays Capital Securities | 3/2 | 96,500 | 1.03% (+0.06%) |
| GOLDMAN SACHS | 2/27 | 127,789 | 1.37% (-0.14%) |
| Barclays Capital Securities | 2/27 | 90,500 | 0.97% (-0.27%) |
| Barclays Capital Securities | 2/25 | 116,400 | 1.24% (+0.18%) |
| JPM Securities Japan Co | 2/25 | 87,900 | 0.94% (+0.07%) |
| GOLDMAN SACHS | 2/24 | 140,889 | 1.51% (-0.16%) |
| Barclays Capital Securities | 2/24 | 99,200 | 1.06% (-0.25%) |
| JPM Securities Japan Co | 2/24 | 81,400 | 0.87% (-0.08%) |
| Nomura | 2/24 | 44,600 | 0.47% (-0.14%) |
| GOLDMAN SACHS | 2/20 | 156,089 | 1.67% (+0.12%) |
| Barclays Capital Securities | 2/20 | 122,080 | 1.31% (+0.29%) |
| JPM Securities Japan Co | 2/20 | 88,700 | 0.95% (+0.06%) |
| Nomura | 2/20 | 56,920 | 0.61% (+0.03%) |
| Barclays Capital Securities | 2/19 | 95,900 | 1.02% (+0.12%) |
| Barclays Capital Securities | 2/18 | 84,320 | 0.90% (+0.45%) |
| Nomura | 2/18 | 54,700 | 0.58% (+0.35%) |
| モルガン・スタンレーMUFG証券 | 2/17 | 147,075 | 1.57% (-0.08%) |
| GOLDMAN SACHS | 2/17 | 144,989 | 1.55% (+0.06%) |
| Barclays Capital Securities | 2/17 | 42,480 | 0.45% (-0.98%) |
| モルガン・スタンレーMUFG証券 | 2/16 | 153,775 | 1.65% (-0.10%) |
| Barclays Capital Securities | 2/16 | 133,420 | 1.43% (+0.04%) |
| Nomura | 2/16 | 22,000 | 0.23% (-0.27%) |
| モルガン・スタンレーMUFG証券 | 2/13 | 163,875 | 1.75% (-0.10%) |
| GOLDMAN SACHS | 2/13 | 138,989 | 1.49% (+0.20%) |
| Barclays Capital Securities | 2/13 | 129,500 | 1.39% (+1.02%) |
| モルガン・スタンレーMUFG証券 | 2/12 | 172,375 | 1.85% (-0.09%) |
| GOLDMAN SACHS | 2/12 | 121,089 | 1.29% (-0.13%) |
| Nomura | 2/12 | 47,300 | 0.50% (+0.50%) |